Nanomedicine is Key to New Generation of Drug Delivery Myth or Reality
Nanomedicine is universally recognised as the driver for the next wave of advancements in detection, diagnosis, treatment and prevention of disease. Next generation therapies will be expected to deliver drugs specifically to sites of disease or tumors in order to maximize clinical benefit while limiting side effects. This workshop is designed to link the theory and practice of nanomedicine formulations with clinical developments and commercialization. It will cover topics that will familiarize individuals from pharmacy, biotech, bioengineering and medical fields with nanotechnology research and its applications in medicine.
- To update individuals on advances in nanotechnology and its application in nanomedicine.
- To discuss current challenges and issues associated with nanomedicine formulations.
- To highlight clinical developments and progress in bringing nanomedicines from bench to market.
- To provide networking and collaboration opportunities for researchers working in nanomedicine.
Who should attend?
- Industry personnel
- Post-graduate students.
- Prof Subbu S. Venkatraman
Chair, Material Science and Engineering, Nayang Technological University, Singapore.
Director, NTU-North-Western Nanomedicine Institute, Singapore.
- A/Prof Wong Tin Wui
Department of Pharmaceutics, Non-Destructive Biomedical and Pharmaceutical Research Centre, iPromise, Universiti Teknology MARA (UiTM), Malaysia.
- Prof Avinash Sonawane
Associate Dean, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, India.
- Dr Stephanie Chan
Acting Head of Bio-process Technologies Research Cluster, Curtin University Sarawak, Malaysia.
REGISTRATION FEE (inclusive of 6% GST)
|Early bird by 20 July 2016||RM350|